Institut Paoli Calmettes Prostate Cancer Database

Prostatic Neoplasms Clinical Trial

Official title:

Institut Paoli Calmettes Prostate Cancer Database

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02869594
• Other study ID #: BDD-PROSTATE-IPC
• Status: Recruiting
• Phase: N/A
• First received: August 11, 2016
• Last updated: August 16, 2016
• Start date: January 2010
• Est. completion date: December 2030

Study information

• Verified date: August 2016
• Source: Institut Paoli-Calmettes
• Contact: Dominique Genre, MD
• Phone: 0033491223778
• Email: drci.up[@]ipc.unicancer.fr
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertés
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Database of Institut Paoli-Calmettes patients diagnosed with prostate cancer

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 2030
• Est. primary completion date: January 2030
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years to 95 Years

Eligibility

Inclusion Criteria:

• Prostatic cancer

Exclusion Criteria:

• Non applicable

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Prostatic Neoplasms

Intervention

Other:
• Data collection

Locations

Country	Name	City	State
France	Institut Paoli-Calmettes	Marseille	Bouches-du Rhône

Sponsors (1)

Lead Sponsor	Collaborator
Institut Paoli-Calmettes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Survival of patients	Overall survival of all patients who come in the center	10 years	No
Secondary	Collection of patients characteristics	Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies	10 years	No